On March 2 and 4, Axinn partners Stacie Ropka and Ted Mathias spoke at the 2020 Festival of Biologics USA in San Diego. This three-day event provided a meeting place for the life science community to bridge the gap between academia and industry.
On March 2, Stacie spoke on a panel entitled, "The FDA’s Current Position on Biosimilars and How the Industry in the U.S. Will Move Forward." This panel covered the introduction of new biosimilars to the market and the effect on U.S. adoption. On March 4, Ted spoke on a panel entitled, "Three Topics Covering the BPCIA’s Past, Present & Future." This panel discussed why Amgen’s Trastuzumab and Bevacizumab launches mattered.